More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$12.99B
EPS
0.56
P/E ratio
19.1
Price to sales
1.84
Dividend yield
2.015%
Beta
0.515635
Previous close
$31.28
Today's open
$31.49
Day's range
$30.96 - $31.59
52 week range
$26.12 - $37.09
show more
CEO
Deepak Nath
Employees
17349
Headquarters
Watford,
Exchange
New York Stock Exchange
Shares outstanding
418708564
Issue type
American Depository Receipt
Healthcare
Medical Equipment & Supplies
Smith & Nephew SNATS Q3 Earnings Call Highlights
Smith & Nephew SNATS NYSE: SNN lowered its full-year revenue and trading profit outlook after continued weakness in its U.S. knee and hip businesses tempered otherwise stronger third-quarter growth.
MarketBeat • Nov 8, 2026

Smith & Nephew: Sluggish Growth And Shifting Outlook Now Make It Less Attractive (Rating Downgrade)
Smith & Nephew faces credibility challenges after a profit warning and lowered guidance, despite recent share price gains. SNN cut the full-year underlying revenue growth forecast to 3% and halved expected trading profit growth to around 4%, citing US Orthopaedics weakness. All three business divisions showed year-to-date revenue growth, with Sports Medicine & ENT delivering double-digit gains, but US Hips and Knees remain soft.
Seeking Alpha • Nov 6, 2026

Smith+Nephew cuts outlook after failed orthopaedics deal talks with J&J
Smith+Nephew cut its full-year revenue and profit forecast on Wednesday as the British medical device maker also confirmed that talks about a potential merger with Johnson & Johnson's (JNJ.N), opens new tab orthopaedics unit have ended.
Reuters • Nov 4, 2026

Smith & Nephew plc (SNN) Q3 2026 Sales/Trading Call Transcript
Smith & Nephew plc (SNN) Q3 2026 Sales/Trading Call Transcript
Seeking Alpha • Nov 4, 2026

Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
SNN expands CARTIHEAL's reach across 12 European markets, backed by five-year clinical data and strong momentum in its Sports Medicine Joint Repair business.
Zacks Investment Research • Oct 8, 2026

Smith+Nephew's revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its innovative CARTIHEAL AGILI-C Cartilage Repair Implant is now commercially available in Europe. The CARTIHEAL Implant will take center stage at this week's International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit in Porto, Portugal from October 8-10.
GlobeNewsWire • Oct 6, 2026

Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l'innovativo impianto per la riparazione della cartilagine, che sarà presentato all'ICRS Summit in Portogallo.
Smith+Nephew (LSE: SN, NYSE: SNN) azienda di tecnologia medica, annuncia il lancio commerciale in Europa di CARTIHEAL AGILI-C, l'innovativo impianto per la riparazione della cartilagine. La tecnologia sarà presentata all'International Cartilage Regeneration & Joint Preservation Society (ICRS) Summit, che si terrà a Porto, in Portogallo, dall'8 al 10 ottobre.
GlobeNewsWire • Oct 6, 2026

Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal
Smith+Nephew (LSE: SN, NYSE: SNN), compañía global de tecnología médica, anuncia hoy que su innovador implante de reparación de cartílago CARTIHEAL AGILI-C ya está disponible para su comercialización en Europa. El implante CARTIHEAL ocupará un lugar destacado en el Congreso de la Sociedad International de Regeneración de Cartílago & Preservación Articular (ICRS), que se celebrará en Oporto (Portugal) del 8 al 10 de octubre.
GlobeNewsWire • Oct 6, 2026

Smith+Nephew Launches EVOS PELVIC System to Advance Trauma Care
SNN expands its trauma portfolio with the EVOS PELVIC System, targeting complex pelvic and acetabular fracture procedures in the United States.
Zacks Investment Research • Sep 30, 2026

Smith+Nephew launches the new EVOS™ PELVIC Plating System at the 2026 Orthopedic Trauma Association (OTA) Annual Meeting, expanding the EVOS Plating Platform for pelvic and acetabular fracture management
The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for trauma surgeons worldwide due to its breadth of implant offerings, procedural efficiency and clinically relevant innovation.1-5 EVOS PELVIC System helps surgeons address a broad range of fracture patterns and disruptions in highly complex procedures.
GlobeNewsWire • Sep 23, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Smith & Nephew SNATS Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.